Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization

Tobaldini, 2020, Sympatho-Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation, J. Clin. Med., 9, 10.3390/jcm9041146 Kreider, 2009, Selection of candidates for lung transplantation, Proc. Am. Thorac. Soc., 6, 20, 10.1513/pats.200808-097GO Levy, 2020, The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation, Am. J. Transplant., 20, 241, 10.1111/ajt.15561 Levy, 2018, Untreated Subclinical Minimal Acute Rejection Does Not Increase the Risk for Chronic Lung Allograft Dysfunction and Death After Lung Transplantation, J Heart Lung Transpl., 37, S442-S, 10.1016/j.healun.2018.01.1146 von Suesskind-Schwendi, 2012, Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection, Eur J Cardio-Thorac., 42, 142, 10.1093/ejcts/ezr277 Knoop, 2006, Acute and chronic rejection after lung transplantation, Semin Resp Crit Care., 27, 521, 10.1055/s-2006-954609 Vadori, 2015, The immunological barriers to xenotransplantation, Tissue Antigens, 86, 239, 10.1111/tan.12669 Corris, 2015, A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation, Thorax, 70, 442, 10.1136/thoraxjnl-2014-205998 Corris, 2012, A Randomised Controlled Trial of Azithromycin Therapy in Bronchiolitis Obliterans Syndrome (BOS) Post Lung Transplantation, J Heart Lung Transpl., 31, S67-S, 10.1016/j.healun.2012.01.178 Shitrit, 2005, Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients, J Heart Lung Transpl., 24, 1440, 10.1016/j.healun.2004.08.006 Meyer, 2014, An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome, Eur. Respir. J., 44, 1479, 10.1183/09031936.00107514 Oray, 2016, Long-term side effects of glucocorticoids, Expert Opin. Drug Saf., 15, 457, 10.1517/14740338.2016.1140743 Ahlmann, 2016, The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy, Cancer Chemother. Pharmacol., 78, 661, 10.1007/s00280-016-3152-1 Jouve, 2019, An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization, Expert Opin. Drug Saf., 18, 285, 10.1080/14740338.2019.1599858 Fang, 2011, Recent progress in medicinal investigations on trichosanthin and other ribosome inactivating proteins from the plant genus Trichosanthes, Curr. Med. Chem., 18, 4410, 10.2174/092986711797200499 Zhou, 2007, Up-regulation of IL-10 expression in dendritic cells is involved in Trichosanthin-induced immunosuppression, Immunol. Lett., 110, 74, 10.1016/j.imlet.2007.03.008 Chou, 1999, Cis-trans complementation of DQA1-DQB1 genes are modulated by DQ alleles: an immunogenetics analysis of DQ association with the down-regulatory function of CD8 cells in trichosanthin-induced immunosuppression, Eur. J. Immunogenet., 26, 5, 10.1046/j.1365-2370.1999.00124.x Zhou, 2007, Immune suppression via IL-4/IL-10-secreting T cells: a nontoxic property of anti-HIV agent trichosanthin, Clin. Immunol., 122, 312, 10.1016/j.clim.2006.11.001 Gong, 2008, Trichosanthin, an extract of Trichosanthes kirilowii, effectively prevents acute rejection of major histocompatibility complex-mismatched mouse skin allograft, Transpl. Proc., 40, 3714, 10.1016/j.transproceed.2008.07.132 Yang, 2014, A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8(+)CD28(-) Tregs, Clin. Immunol., 153, 277, 10.1016/j.clim.2014.05.005 Wang, 2010, A role for trichosanthin in the expansion of CD4CD25 regulatory T cells, Scand. J. Immunol., 71, 258, 10.1111/j.1365-3083.2010.02372.x Byers, 1990, A phase I/II study of trichosanthin treatment of HIV disease, AIDS, 4, 1189, 10.1097/00002030-199012000-00002 Byers, 1994, A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents, AIDS Res. Hum. Retroviruses, 10, 413, 10.1089/aid.1994.10.413 Moiola, 2019, Stapled Peptides-A Useful Improvement for Peptide-Based Drugs, Molecules, 24, 10.3390/molecules24203654 Sato, 2006, Therapeutic peptides: technological advances driving peptides into development, Curr. Opin. Biotechnol., 17, 638, 10.1016/j.copbio.2006.10.002 Muttenthaler, 2021, Trends in peptide drug discovery, Nat. Rev. Drug Discov., 20, 309, 10.1038/s41573-020-00135-8 Chou, 2008, NYGSLLYZYMKK. Effect of Trichosanthin-derived peptide on activating CD8 regulatory T cells to treat experimental autoimmune encephalomyelitis, J. Current Immunol., 28, 4 Wang, 2018, Peptide Tk-PQ induces immunosuppression in skin allogeneic transplantation via increasing Foxp3(+) Treg and impeding nuclear translocation of NF-kappa B, Mol. Immunol., 101, 597, 10.1016/j.molimm.2018.05.006 Li, 2016, A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene, Immunology, 147, 355, 10.1111/imm.12569 Shi, 2013, Impact of polyclonal anti-CD3/CD28-coated magnetic bead expansion methods on T cell proliferation, differentiation and function, Int. Immunopharmacol., 15, 129, 10.1016/j.intimp.2012.10.023 Dillon, 2018, A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgD) Potently Suppresses Human Mixed Lymphocyte Reactions and Human/NSG Mouse Xenograft Graft vs, Host Disease (GvHD). Biol Blood Marrow Tr., 24, S187, 10.1016/j.bbmt.2017.12.141 Fan, 2013, Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis, Transpl. Immunol., 28, 170, 10.1016/j.trim.2013.04.006 Jure-Kunkel, 2013, Nonclinical evaluation of the combination of mouse IL-21 and anti- mouse CTLA-4 or PD-1 blocking antibodies in mouse tumor models, J. Clin. Oncol., 31 Liu, 2001, B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis, J. Immunol., 167, 1830, 10.4049/jimmunol.167.3.1830 Togashi, 2019, Regulatory T cells in cancer immunosuppression - implications for anticancer therapy, Nat. Rev. Clin. Oncol., 16, 356, 10.1038/s41571-019-0175-7 Hafner, 2004, Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers, Clin. Chem., 50, 490, 10.1373/clinchem.2003.026849 Bertoni, 2018, Integrins in T Cell Physiology, Int. J. Mol. Sci., 19, 10.3390/ijms19020485 Khan, 2020, Hypoxia-induced complement dysregulation is associated with microvascular impairments in mouse tracheal transplants, J. Transl. Med., 18, 10.1186/s12967-020-02305-z Yu, 2020, Effect of gestational and lactational nonylphenol exposure on airway inflammation in ovalbumin-induced asthmatic rat pups, Chemosphere, 250, 10.1016/j.chemosphere.2020.126244 Yu, 2020, Toxic effects of perinatal maternal exposure to nonylphenol on lung inflammation in male offspring rats, Sci. Total Environ., 737, 10.1016/j.scitotenv.2020.139238 Wang, 2020, MiRNA-451a inhibits airway remodeling by targeting Cadherin 11 in an allergic asthma model of neonatal mice, Int. Immunopharmacol., 83, 10.1016/j.intimp.2020.106440 Yu, 2020, PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation, Aging-Us., 12, 11636, 10.18632/aging.103330 Larsson-Callerfelt, 2020, VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation, Resp Med., 166, 10.1016/j.rmed.2020.105944 Gao, 2020, Derivation of induced pluripotent stem cells from ferret somatic cells, Am J Physiol-Lung C, 318, L671, 10.1152/ajplung.00456.2019 Wu, 2014, Peptide-based cancer therapy: opportunity and challenge, Cancer Lett., 351, 13, 10.1016/j.canlet.2014.05.002 Fosgerau, 2015, Peptide therapeutics: current status and future directions, Drug Discov. Today, 20, 122, 10.1016/j.drudis.2014.10.003 Davda, 2019, Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics, J. Immunother. Cancer, 7, 105, 10.1186/s40425-019-0586-0 Wang, 2022, Therapeutic peptides: current applications and future directions, Signal Transduct. Target. Ther., 7, 48, 10.1038/s41392-022-00904-4 Murata, 2001, Asymmetric arrangement of auxiliary subunits of skeletal muscle voltage-gated L-type Ca2+ channel, Biochem Bioph Res Co., 282, 284, 10.1006/bbrc.2001.4529 Zhao, 2006, Trichosanthin Induced Th2 Polarization Status, Cell. Mol. Immunol., 3, 297 Wang, 2010, Phenotypic alterations of dendritic cells are involved in suppressive activity of trichosanthin-induced CD8+CD28- regulatory T cells, J. Immunol., 185, 79, 10.4049/jimmunol.0901488 Garg, 2016, Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma, Sci. Transl. Med., 8, 10.1126/scitranslmed.aae0105 Betts, 2018, Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation, P Natl Acad Sci USA, 115, 1582, 10.1073/pnas.1712452115 Sauer, 2008, T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR, P Natl Acad Sci USA, 105, 7797, 10.1073/pnas.0800928105 Huynh, 2015, Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability, Nat. Immunol., 16, 188, 10.1038/ni.3077 Shrestha, 2015, Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses, Nat. Immunol., 16, 178, 10.1038/ni.3076 Bansal, 2017, Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases, Exp. Mol. Med., 49, e396, 10.1038/emm.2017.213 Meecham, 2020, The ITGB6 gene: its role in experimental and clinical biology, Gene, 763S